These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. Lapchak PA; Araujo DM Am J Cardiovasc Drugs; 2003; 3(2):87-94. PubMed ID: 14727935 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence. Pancioli AM; Brott TG CNS Drugs; 2004; 18(14):981-8. PubMed ID: 15584768 [TBL] [Abstract][Full Text] [Related]
5. Glicoprotein (GP) IIb/IIIa inhibitors for acute stroke treatment. Bogousslavsky J; Paciaroni M; Gallai V Clin Exp Hypertens; 2002; 24(7-8):603-10. PubMed ID: 12450235 [TBL] [Abstract][Full Text] [Related]
6. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator. Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117 [TBL] [Abstract][Full Text] [Related]
7. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions. Yoon HC; Miller FJ AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048 [TBL] [Abstract][Full Text] [Related]
9. Therapy for early reperfusion after stroke. Juttler E; Kohrmann M; Schellinger PD Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798 [TBL] [Abstract][Full Text] [Related]
10. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice]. Haerten K; Krabbe C; Raiber M Dtsch Med Wochenschr; 2004 Mar; 129(12):607-10. PubMed ID: 15011129 [TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy. Shuaib A; Yang Y; Nakada MT; Li Q; Yang T J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719 [TBL] [Abstract][Full Text] [Related]
14. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke. Yang M; Huo X; Miao Z; Wang Y Drugs; 2019 Apr; 79(5):515-529. PubMed ID: 30838514 [TBL] [Abstract][Full Text] [Related]
15. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke. Lapchak PA; Araujo DM; Song D; Zivin JA Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904 [TBL] [Abstract][Full Text] [Related]
16. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. Feldman DN; Wong SC; Bergman G; Minutello RM J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400 [TBL] [Abstract][Full Text] [Related]